These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1331445)

  • 1. Novel positive inotropic agents: synthesis and biological activities of 6-(3-amino-2-hydroxypropoxy)-2(1H)-quinolinone derivatives.
    Fujioka T; Teramoto S; Mori T; Hosokawa T; Sumida T; Tominaga M; Yabuuchi Y
    J Med Chem; 1992 Oct; 35(20):3607-12. PubMed ID: 1331445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological activities of optically active 6-[3-(3,4-dimethoxybenzylamino)-2-hydroxypropoxy]-2(1H)-quinolinone (OPC-18790).
    Fujioka T; Teramoto S; Tsujimi S; Takemoto K; Mori T; Hosokawa T; Sumida T; Tominaga M; Yabuuchi Y
    Chem Pharm Bull (Tokyo); 1996 Aug; 44(8):1596-8. PubMed ID: 8795279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2(1H)-quinolinones with cardiac stimulant activity. 2. Synthesis and biological activities of 6-(N-linked, five-membered heteroaryl) derivatives.
    Alabaster CT; Bell AS; Campbell SF; Ellis P; Henderson CG; Morris DS; Roberts DA; Ruddock KS; Samuels GM; Stefaniak MH
    J Med Chem; 1989 Mar; 32(3):575-83. PubMed ID: 2537423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive inotropic and negative chronotropic effects of OPC-8490, a newly developed cardiotonic, in isolated, blood-perfused canine heart preparations.
    Furukawa Y; Akahane K; Haniuda M; Chiba S
    Jpn Heart J; 1989 May; 30(3):387-98. PubMed ID: 2552190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular actions of OPC-18790: a novel positive inotropic agent with little chronotropic action.
    Hosokawa T; Mori T; Fujiki H; Kinoshita S; Takemoto K; Imaizumi T; Noda T; Ohura M; Tominaga M; Yabuuchi Y
    Heart Vessels; 1992; 7(2):66-75. PubMed ID: 1328145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The progress towards the development of DHQO derivatives and related analogues with inotropic effects.
    Wu Y; Piao HR
    Mini Rev Med Chem; 2013 Oct; 13(12):1801-11. PubMed ID: 24032511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OPC-18790, a novel positive inotropic agent, has both arterial and venous vascular dilating actions in the dog.
    Fujiki H; Mori T; Yoshida K; Imaizumi T; Tominaga M
    Eur J Pharmacol; 1996 Oct; 313(3):191-200. PubMed ID: 8911915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiotonic activity of a new inotropic agent, 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), in the dog with and without beta-blocker and Ca++-antagonist pretreatment.
    Hori M; Inoue M; Tamai J; Koretsune Y; Kitakaze M; Iwai K; Ito H; Kitabatake A; Kamada T
    Jpn Circ J; 1986 Jan; 50(1):37-44. PubMed ID: 3702034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo studies of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), a novel positive inotropic drug, in various animals.
    Yamashita S; Hosokawa T; Kojima M; Mori T; Yabuuchi Y
    Arzneimittelforschung; 1984; 34(3A):342-6. PubMed ID: 6331464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute hemodynamic effects of a new positive inotropic agent, 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), in conscious and anesthetized dogs.
    Miyazaki S; Sasayama S; Nakamura Y; Kihara Y; Susawa T; Kawai C
    J Cardiovasc Pharmacol; 1986; 8(1):14-20. PubMed ID: 2419676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on positive inotropic agents. IV. Synthesis of 5-(3-amino-2-hydroxypropoxy)-3,4-dihydro-8-hydroxy-2(1H)-quinolinone derivatives.
    Tominaga M; Ogawa H; Yo E; Yamashita S; Yabuuchi Y; Nakagawa K
    Chem Pharm Bull (Tokyo); 1987 Sep; 35(9):3699-704. PubMed ID: 3435968
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of toborinone on myocardial oxygen consumption in pacing-induced heart failure dogs.
    Itoh S; Mori T; Fujiki H; Tominaga M
    Arzneimittelforschung; 1996 Dec; 46(12):1105-9. PubMed ID: 9006782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2(1H)-quinolinones with cardiac stimulant activity. 1. Synthesis and biological activities of (six-membered heteroaryl)-substituted derivatives.
    Alabaster CT; Bell AS; Campbell SF; Ellis P; Henderson CG; Roberts DA; Ruddock KS; Samuels GM; Stefaniak MH
    J Med Chem; 1988 Oct; 31(10):2048-56. PubMed ID: 2845085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mode and mechanism of action of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), a novel positive inotropic drug, on the dog heart.
    Taira N; Endoh M; Iijima T; Satoh K; Yanagisawa T; Yamashita S; Maruyama M; Kawada M; Morita T; Wada Y
    Arzneimittelforschung; 1984; 34(3A):347-55. PubMed ID: 6331465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2(1H)-quinolinones with cardiac stimulant activity. 3. Synthesis and biological properties of 6-imidazol-1-yl derivatives.
    Bell AS; Campbell SF; Morris DS; Roberts DA; Stefaniak MH
    J Med Chem; 1989 Jul; 32(7):1552-8. PubMed ID: 2544726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl] -2(1H)-quinolinone (OPC-8212), a new inotropic agent, on cardiotonic activity and coronary hemodynamics.
    Inoue M; Hori M; Nakajima S; Kitakaze M; Fukunami M; Ishida Y; Abe H
    Arzneimittelforschung; 1984; 34(3A):355-9. PubMed ID: 6540088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular effects of the combination of OPC-18790 and dopamine in halothane-anesthetized dogs.
    Itoh S; Mori T; Yoshida K; Fujiki H; Tominaga M; Yabuuchi Y
    Jpn J Pharmacol; 1995 Nov; 69(3):229-37. PubMed ID: 8699631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties.
    Uchida Y; Kawada M; Sawanobori K; Sonoki H; Inoue K; Mizuno K; Itou T; Tabunoki Y; Tsukamoto M; Ohashi Y; Kyotani Y; Shimizu N; Fujii M; Nakamura M
    Arzneimittelforschung; 1998 Mar; 48(3):219-31. PubMed ID: 9553677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blocking effects of V1 (OPC-21268) and V2 (OPC-31260) antagonists on the negative inotropic response to vasopressin in isolated dog heart preparations.
    Furukawa Y; Takayama S; Ren LM; Sawaki S; Inoue Y; Chiba S
    J Pharmacol Exp Ther; 1992 Nov; 263(2):627-31. PubMed ID: 1331408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the positive inotropic action of 6,7-dimethoxy-3-cyano-3,4-dihydrocarbostyril.
    Ferrini R; Miragoli G; Calabi ML; Santangelo F; Godfraind T; Bravo G; Casagrande C
    Arzneimittelforschung; 1996 Feb; 46(2):139-45. PubMed ID: 8720302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.